Pharma companies caught in the storm of lawsuits can navigate potential reputation damage with planning and purpose (Illustration: Assistant editor Kathy Wong for Endpoints News)

Phar­ma's day in court: Is the dai­ly down­pour of law­suits giv­ing phar­ma com­pa­nies a bad rep?

Every day seems like law­suit day in the phar­ma in­dus­try. Le­gal fil­ings over patent dis­putes, per­ceived mar­ket­ing mis­steps and ad­verse event drug claims are of­ten just a typ­i­cal week for Big Phar­ma.

But what does all that lit­i­ga­tion mean for com­pa­nies? The tidal wave of law­suits cer­tain­ly trig­gers ex­pens­es. Most phar­ma com­pa­nies re­tain teams of lawyers and cri­sis pub­lic re­la­tions man­agers — and ear­mark mil­lions of dol­lars in bud­gets every year for po­ten­tial lit­i­ga­tion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.